Research Article
BibTex RIS Cite

Prognostic Significance of Monocyte to High-density Lipoprotein Ratio in Patients With Chronic Coronary Artery Occlusion

Year 2022, Volume: 49 Issue: 1, 12 - 20, 11.03.2022
https://doi.org/10.5798/dicletip.1085926

Abstract

References

  • 1.Fefer P, Knudtson ML, Cheema AN, et all. Currentperspectives on coronary chronic total occlusions:the Canadian Multicenter Chronic Total OcclusionsRegistry. J Am Coll Cardiol 2012; 59: 991–7.
  • 2.Jeroudi OM, Alomar ME, Michael TT, et all.Prevalence and management of coronary chronictotal occlusions in a tertiary Veterans Affairshospital. Catheter Cardiovasc Interv 2014; 84:637–43.
  • 3.Stone GW, Kandzari DE, Mehran R, et all.Percutaneous recanalization of chronically occludedcoronary arteries: a consensus document: part I.Circulation 2005; 112:2364–72.

Prognostic Significance of Monocyte to High-density Lipoprotein Ratio in Patients With Chronic Coronary Artery Occlusion

Year 2022, Volume: 49 Issue: 1, 12 - 20, 11.03.2022
https://doi.org/10.5798/dicletip.1085926

Abstract

Objective: Monocyte to high-density lipoprotein ratio (MHR) is a biomarker of inflammatory response. In this study, we investigated the relationship between MHR and mortality in patients with chronic coronary artery occlusion (CTO).
Method: Retrospective observational study including 493 patients over a follow up period of 73 months. Blood samples were taken before cardiac catheterization for coronary angiography.
Results: Median follow-up was 48 months(26-73) . Patients were seperated into two groups: (I) MHR <17.68 (n=278, 95 females) and (II) MHR ≥17.68 (n=215, 45 females). Mortality was considerably higher in MHR II than in MHR I (n=70 vs. n=43; p<0,001). MHR was an independent predictor of mortality (OR: 1.089, 95% [CI]: 1.055-1.124, p<0,001). Lower survival rates were found in MHR II on Kaplan-Meier analyses when compared to that of MHR I (75.223±2.670 vs. 89.220±2.102, p<0,001).
Conclusions: As a simple, easy applicable and universal marker, MHR may be a parameter that predicts mortality risk and survival time in CTO patients.

References

  • 1.Fefer P, Knudtson ML, Cheema AN, et all. Currentperspectives on coronary chronic total occlusions:the Canadian Multicenter Chronic Total OcclusionsRegistry. J Am Coll Cardiol 2012; 59: 991–7.
  • 2.Jeroudi OM, Alomar ME, Michael TT, et all.Prevalence and management of coronary chronictotal occlusions in a tertiary Veterans Affairshospital. Catheter Cardiovasc Interv 2014; 84:637–43.
  • 3.Stone GW, Kandzari DE, Mehran R, et all.Percutaneous recanalization of chronically occludedcoronary arteries: a consensus document: part I.Circulation 2005; 112:2364–72.
There are 3 citations in total.

Details

Primary Language English
Subjects Health Care Administration
Journal Section Original Articles
Authors

Muhammed Demir This is me

Mehmet Özbek This is me

Adem Aktan This is me

Tuncay Güzel This is me

Burhan Aslan This is me

Hakkı Şimşek This is me

Publication Date March 11, 2022
Submission Date October 4, 2021
Published in Issue Year 2022 Volume: 49 Issue: 1

Cite

APA Demir, M., Özbek, M., Aktan, A., Güzel, T., et al. (2022). Prognostic Significance of Monocyte to High-density Lipoprotein Ratio in Patients With Chronic Coronary Artery Occlusion. Dicle Tıp Dergisi, 49(1), 12-20. https://doi.org/10.5798/dicletip.1085926
AMA Demir M, Özbek M, Aktan A, Güzel T, Aslan B, Şimşek H. Prognostic Significance of Monocyte to High-density Lipoprotein Ratio in Patients With Chronic Coronary Artery Occlusion. diclemedj. March 2022;49(1):12-20. doi:10.5798/dicletip.1085926
Chicago Demir, Muhammed, Mehmet Özbek, Adem Aktan, Tuncay Güzel, Burhan Aslan, and Hakkı Şimşek. “Prognostic Significance of Monocyte to High-Density Lipoprotein Ratio in Patients With Chronic Coronary Artery Occlusion”. Dicle Tıp Dergisi 49, no. 1 (March 2022): 12-20. https://doi.org/10.5798/dicletip.1085926.
EndNote Demir M, Özbek M, Aktan A, Güzel T, Aslan B, Şimşek H (March 1, 2022) Prognostic Significance of Monocyte to High-density Lipoprotein Ratio in Patients With Chronic Coronary Artery Occlusion. Dicle Tıp Dergisi 49 1 12–20.
IEEE M. Demir, M. Özbek, A. Aktan, T. Güzel, B. Aslan, and H. Şimşek, “Prognostic Significance of Monocyte to High-density Lipoprotein Ratio in Patients With Chronic Coronary Artery Occlusion”, diclemedj, vol. 49, no. 1, pp. 12–20, 2022, doi: 10.5798/dicletip.1085926.
ISNAD Demir, Muhammed et al. “Prognostic Significance of Monocyte to High-Density Lipoprotein Ratio in Patients With Chronic Coronary Artery Occlusion”. Dicle Tıp Dergisi 49/1 (March 2022), 12-20. https://doi.org/10.5798/dicletip.1085926.
JAMA Demir M, Özbek M, Aktan A, Güzel T, Aslan B, Şimşek H. Prognostic Significance of Monocyte to High-density Lipoprotein Ratio in Patients With Chronic Coronary Artery Occlusion. diclemedj. 2022;49:12–20.
MLA Demir, Muhammed et al. “Prognostic Significance of Monocyte to High-Density Lipoprotein Ratio in Patients With Chronic Coronary Artery Occlusion”. Dicle Tıp Dergisi, vol. 49, no. 1, 2022, pp. 12-20, doi:10.5798/dicletip.1085926.
Vancouver Demir M, Özbek M, Aktan A, Güzel T, Aslan B, Şimşek H. Prognostic Significance of Monocyte to High-density Lipoprotein Ratio in Patients With Chronic Coronary Artery Occlusion. diclemedj. 2022;49(1):12-20.